In the chronic hepatitis C group with significant fibrosis (CHC-SF), albumin and platelet (PLT) levels were significantly lower in comparison with the chronic hepatitis C group with non-significant fibrosis (CHC-NSF), NASH and CG. The gene discussed is ALB; the disease is metabolic dysfunction-associated steatohepatitis.